<div id="readability-page-1"><p>Blend Labs, Inc. (NYSE:BLND - Get Free Report) traded down 5.4% during mid-day trading on Monday following insider selling activity. The company traded as low as $3.69 and last traded at $3.70. 897,526 shares changed hands during mid-day trading, a decline of 61% from the average session volume of 2,313,856 shares. The stock had previously closed at $3.91.</p><p>Specifically, insider Winnie Ling sold 20,000 shares of Blend Labs stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $3.33, for a total transaction of $66,600.00. Following the transaction, the insider now owns 286,416 shares of the company's stock, valued at approximately $953,765.28. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several analysts have issued reports on BLND shares. William Blair raised shares of Blend Labs from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating in a research report on Friday, August 9th. Keefe, Bruyette &amp; Woods lifted their price objective on shares of Blend Labs from $3.00 to $3.25 and gave the company a &#34;market perform&#34; rating in a research note on Monday, August 12th. Canaccord Genuity Group upgraded Blend Labs from a &#34;hold&#34; rating to a &#34;buy&#34; rating and lifted their price target for the company from $3.00 to $4.75 in a research note on Monday, August 12th. Canaccord Genuity Group raised Blend Labs from a &#34;hold&#34; rating to a &#34;buy&#34; rating and boosted their target price for the stock from $3.00 to $4.75 in a research note on Monday, August 12th. Finally, The Goldman Sachs Group lifted their price target on shares of Blend Labs from $3.00 to $3.40 and gave the company a &#34;buy&#34; rating in a report on Friday, August 9th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $3.93.</p><p><b>Get Our Latest Stock Report on BLND</b></p><h2>Blend Labs Stock Performance</h2><p>The firm has a 50-day moving average price of $3.26 and a 200-day moving average price of $2.91. The stock has a market cap of $941.37 million, a P/E ratio of -6.74 and a beta of 1.15. </p><p>Blend Labs (NYSE:BLND - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.10) by $0.04. The company had revenue of $40.48 million for the quarter, compared to analysts' expectations of $39.50 million. Blend Labs had a negative net margin of 77.63% and a negative return on equity of 595.99%. On average, research analysts predict that Blend Labs, Inc. will post -0.27 earnings per share for the current year. </p><h2>Institutional Investors Weigh In On Blend Labs</h2><p>Several institutional investors have recently made changes to their positions in the company. Formation8 GP LLC acquired a new stake in Blend Labs during the 4th quarter valued at approximately $41,362,000. Vanguard Group Inc. increased its position in Blend Labs by 0.5% during the first quarter. Vanguard Group Inc. now owns 9,249,111 shares of the company's stock worth $30,060,000 after purchasing an additional 46,526 shares during the last quarter. ShawSpring Partners LLC raised its holdings in Blend Labs by 58.7% in the 2nd quarter. ShawSpring Partners LLC now owns 6,716,144 shares of the company's stock valued at $15,850,000 after buying an additional 2,485,283 shares during the period. Acadian Asset Management LLC lifted its stake in Blend Labs by 8.6% during the 2nd quarter. Acadian Asset Management LLC now owns 780,274 shares of the company's stock worth $1,840,000 after acquiring an additional 62,000 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Blend Labs by 3,799.4% in the second quarter. Bank of New York Mellon Corp now owns 654,897 shares of the company's stock valued at $1,546,000 after purchasing an additional 638,102 shares in the last quarter. Institutional investors own 52.56% of the company's stock. </p><h2>Blend Labs Company Profile</h2> (Get Free Report)<p>Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Blend Labs</li><li>What Are Dividend Challengers?</li><li>Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible</li><li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li><li>Roblox's Growth Beyond Kids: Stock Set for Major Moves</li><li>3 Natural Gas Stocks That Offer Great Dividend Yields</li><li>5 Oversold Stocks to Buy Right Now</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ War on Elon Escalates…  <span><span>(From Porter &amp; Company)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NTgx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NTgx"/></p><h2>Should you invest $1,000 in Blend Labs right now?</h2><p>Before you consider Blend Labs, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.</p><p>While Blend Labs currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p> </div>

BLND

<p>Blend Labs (NYSE:BLND) shares fell 5.4% amid insider selling, with 20,000 shares sold by insider Winnie Ling at $0.33 each. The stock traded as low as $0.69, with a significant drop in trading volume. Analysts have mixed ratings, with some upgrading the stock to 'buy' and raising price targets. The company reported a quarterly EPS of -$0.06, slightly better than expected, but with a negative net margin of 77.63%. Institutional investors hold over 52% of the stock, indicating significant interest in the company.</p>

Blend Labs (NYSE:BLND) Trading Down 5.4% on Insider Selling